ELEV
RhumbLine Advisers’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,732
| Closed | -$20.4K | – | 4179 |
|
|
2025
Q1 | $20.4K | Buy |
78,732
+8,697
| +12% | +$2.25K | ﹤0.01% | 3734 |
|
|
2024
Q4 | $39.4K | Buy |
70,035
+5,429
| +8% | +$3.06K | ﹤0.01% | 3705 |
|
|
2024
Q3 | $38.8K | Sell |
64,606
-304
| -0.5% | -$182 | ﹤0.01% | 3726 |
|
|
2024
Q2 | $175K | Buy |
+64,910
| New | +$175K | ﹤0.01% | 3303 |
|